Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

University of Sheffield trial highlights immunotherapy-related improved survival rates for bladder cancer patients

January 14, 2025 Research and Development Endocrinology, Oncology, Sheffield, astranzeneca, bladder cancer, immunotherapy, patients

The University of Sheffield, UK, have announced study results for its trial into the survival rates of patients with operable …
News

AnaCardio raises $19m in funding round for heart failure candidate

January 10, 2025 Research and Development AnaCardio, Cardiology, cardiology, funding, heart failure

Swedish biopharmaceutical company AnaCardio has announced the completion of a Series A extension financing round that has raised $19m for …
News

University of Southern Denmark pairs with Argobio to launch next-generation RNA company Inverna Therapeutics

January 7, 2025 Research and Development Argobio, Huntingdon's Disease, Inverna therapeutics, Neurology, RNA therapeutics, University of Southern Denmark ], gene splicing

The launch of new RNA company Inverna Therapeutics was announced today. Inerva Therapeutics begins with a programme aimed at transforming …
News

NDA in China receives priority review status for lung cancer treatment

January 3, 2025 Research and Development China, China National Medical products Administration, HUTCHMED, NDA, Oncology, epidermal growth factor receptor, non-small cell lung cancer, priority review

HUTCHMED have announced that the China National Medical Products Administration (NMPA) have granted a priority review for a new drug …
News

UCB presents epilepsy research at American Epilepsy Society Annual Meeting

December 9, 2024 Research and Development American Epilepsy Society, Dravet Syndrome, Neurology, UCB, sleep

Belgian-based biopharmaceutical company UCB has announced it will present 32 abstracts at the American Epilepsy Society (AES) Annual Meeting – …
News

Antibacterial peptides instrumental in efficiency against resistant bacteria

November 18, 2024 Research and Development AMR, Chalmers Institute of Technology, Infections and infestations, MRSA, antibacterial peptides

This month, the Chalmers University of Technology in Sweden have published the results of a study demonstrating that resistant bacteria, …
News

Spinal cord stimulator with AI technology receives CE Mark certification

November 13, 2024 Research and Development AI, EU, Nevro, Pain, spinal cord stimulation

The HFC iQ, a personalised spinal cord stimulation (SCS) system developed by Nevro that leverages AI technology to manage chronic …
News

J&J seek approval for first drug to treat high-risk smoldering myeloma

November 13, 2024 Research and Development FDA, J&J, Rare Diseases, bone marrow

Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the …
News

Theramex receives recommendation for YSELTY in Scotland

November 11, 2024 Research and Development Pain, Reproductive health, appproval, tumours, women's health

Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …
News

Johnson & Johnson receive MHRA approval for BALVERSA

November 8, 2024 Research and Development J&J Innovative Medicine, Oncology, Urology, bladder cancer

BALVERSA (erdafitinib) has been granted marketing approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment …
News

SolasCure partners with US Army for better wound care technology

November 6, 2024 Research and Development Dressings, hosiery & appliances, Solascare, US army, wound care, wound gel

SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …
News

NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink

November 5, 2024 Research and Development NorthWest Ehealth, clinical trials

The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies …
News
Press release

University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma

October 30, 2024 Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors

Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …
News

HIV vaccine candidate successfully optimised for industrial production

October 30, 2024 Research and Development HIV, HIV/AIDS, Naobios, Sumagen, Vaccine, agreement

Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise …
News
cancer_drip_2

Chiesi announces phase 3 results from enzyme-replacement study

October 29, 2024 Research and Development Internal Medicine, Rare Diseases, chiesi Global rare diseases, clinical trials, pharma, rare diseases

Chiesi Global Rare Diseases have announced the results from their BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025